ABC
NKTR icon

Associated Banc-Corp’s Nektar Therapeutics NKTR Stock Holding History

Associated Banc-Corp’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9
Closed -$2K – 663
2020
Q4 		$2K Buy
9
+4
+80% +$1.03K ﹤0.01% 809
2020
Q3 		$1K Hold
5
– – ﹤0.01% 898
2020
Q2 		$2K Buy
+5
New +$1.56K ﹤0.01% 709

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Associated Banc-Corp's NKTR Position: Q1 2021 in Review

Associated Banc-Corp sold out of Nektar Therapeutics (NKTR) in Q1 2021, closing a stake of 9 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in NKTR in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 236 funds tracked by Wall St. Rank hold NKTR as of Q1 2021.

  • Associated Banc-Corp reported no remaining Nektar Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 9 Nektar Therapeutics shares in Q1 2021, an estimated $2K.
  • Associated Banc-Corp first reported a position in Nektar Therapeutics in Q2 2020 and held it in 3 quarters.
  • Associated Banc-Corp's Nektar Therapeutics position peaked at $2K in Q4 2020.
  • 236 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.